Treatment with PCSK9 inhibitors in patients with chronic kidney disease at very high cardiovascular risk

  1. Amaro, J.M.
  2. Villanego, F.
  3. Naranjo, J.
  4. Orellana, C.
  5. Vigara, L.A.
  6. Narváez, C.E.
  7. Torrado, J.
  8. Cazorla, J.M.
  9. Rodríguez, C.
  10. Mazuecos, A.
Aldizkaria:
Nefrologia

ISSN: 2013-2514 0211-6995

Argitalpen urtea: 2023

Zenbakien izenburua: Número Especial Diciembre

Alea: 43

Orrialdeak: 132-135

Mota: Gutuna

DOI: 10.1016/J.NEFRO.2022.11.006 GOOGLE SCHOLAR lock_openSarbide irekia editor